Develops drugs for cardiovascular and Central Nervous System diseases.
Jun 2026Revenue $821K/yrExpenses $40.9M/yr
No trendCash runway ≈ 7 months from Jun 2026
Figures by year
When will Scienture Holdings be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $821K and expenses $40.9M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $432K | $43.0M | −$42.6M |
| Dec 2024 | $137K | $14.8M | −$14.7M |
| Dec 2023 | $1.36M | $5.76M | −$4.40M |
| Dec 2022 | $10.3M | $13.2M | −$2.92M |
| Dec 2021 | $9.89M | $15.2M | −$5.29M |
| Dec 2020 | $17.1M | $19.6M | −$2.51M |
| Dec 2019 | $7.44M | $7.31M | $125K |
| Dec 2018 | $3.83M | $3.92M | −$87.6K |
| Dec 2017 | $2.93M | $2.54M | $395K |
| Dec 2016 | $2.48M | $3.49M | −$1.01M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.